Genetically engineered models have advantages over xenografts for preclinical studies

Cancer Research

Volumn 66, Issue 7, 2006, Pages 3355-3358

  Becher, Oren J ^a   Holland, Eric C ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Memorial Sloan Kettering Cancer Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; IMATINIB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL FACTOR;

BIOLUMINESCENCE; CANCER RESEARCH; CARCINOGENESIS; CHRONIC MYELOID LEUKEMIA; DRUG INHIBITION; GENE TRANSFER; HUMAN; IN VIVO STUDY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; XENOGRAFT;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG SCREENING ASSAYS, ANTITUMOR; GENETIC ENGINEERING; HUMANS; MICE; MICE, TRANSGENIC; NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33645736793     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-3827     Document Type: Review

References (20)

1. Adams JM, Harris AW, Pinkert CA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985;318:533-8.
2. Brinster RL, Chen HY, Messing A, et al. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 1984;37:367-79.
3. Hanahan D. Transgenic mice as probes into complex systems. Science 1989;246:1265-75.
4. Stewart TA, Pattengale K, Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 1984;38:627-37.
5. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992;89:5547-51.
6. Petropoulos CJ, Hughes SH. Replication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells. J Virol 1991;65:3728-37.
7. Bates P, Young JA, Varmus HE. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell 1993;74:1043-51.
8. Fisher GH, Orsulic S, Holland E, et al. Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene 1999;18:5253-60.
9. Perl AK, Dahl U, Wilgenbus P, et al. Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic β tumor cells. Nat Med 1999;5:286-91.
10. Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-44.
11. Rego KM, Li-Zhen H, Warrell RP, et al. Retinoic acid and arsenic oxide treatment in transgenic models of acute promyclocytic leukemia unravel the distinct nature of the leukemogenic process induced by the PML-RARα and PLZF-RARα oncoproteins. Proc Natl Acad Sci U S A 2000;97:10173-8.
12. Druker BJ. Perspectives on the development of a molecularly targeted agent. Cancer Cell 2002;1:31-6.
13. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-14.
14. Hoover RR, Mahon FX Melo JV, et al. Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336. Blood 2002;100:1068-71.
15. Le Coutre P, Mologni L, Cleris L, et al. In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor. J Natl Cancer Inst 1999;91:163-8.
16. Rosenberg MP, Bortner D. Why transgenic and knockout animal models should be used (for drug efficacy studies in cancer). Cancer Metastasis Rev 1999;17:295-9.
17. Koutcher JA, Hu X, Xu S, et al. MR imaging of mouse models for gliomas show similarities to humans and can be used to identify mice for preclinical trials. Neoplasia 2002;4:480-5.
18. Lyons SK, Meuwissen R, Krimpenfort P, et al. The generation of a conditional reporter that enables bioluminescence imaging of a Cre/loxP-dependent tumorigenesis in mice. Cancer Res 2003;63:7042-6.
19. Uhrbom L, Holland EC. Modelling gliomagenesis with somatic cell gene transfer using retroviral vectors. J Neurooncol 2001;53:297-305.
20. Holland EC, editor. Mouse models of human cancer. Vol. 26. Hoboken (NJ): Wiley-Liss; 2004. p. 437-44.